Eye Meds Now

 Quick Ophthalmic Drug Search

224 items found
FAMCICLOVIR (famciclovir (125 mg; 250 mg; 500 mg) tablets)
Prescription
Oral
Tablets
Antivirals
Indications/Usage:

Indicated for the treatment of acute herpes zoster (shingles) in immunocompetent adult patients.

The efficacy of famciclovir when initiated more than 72 hours after onset of rash has not been established.

Limitations of use:

The efficacy and safety of famciclovir have not been established for:

  • Patients with ophthalmic zoster
  • Immunocompromised patients other than for the treatment of recurrent orolabial or genital herpes in HIV-infected patients.

Consult package insert for additional information.


Typical Dosing:  

►Acute herpes zoster (shingles):

  • 500 mg every 8 hours for 7 days.
  • Therapy should be initiated as soon as herpes zoster is diagnosed.

►Acute herpes simplex keratitis:

  • 250 mg every 8 hours for 7 – 10 days.
Dosing for herpes simplex keratitis is based on professional judgment. This is our medical opinion and may not be true in all clinical circumstances.

How Supplied:  
  • 125 mg tablets
  • 250 mg tablets
  • 500 mg tablets

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 77°F (25°C).
  • Excursions permitted to 59° – 86°F (15° – 30°C).


FEXOFENADINE (fexofenadine hydrochloride (60 mg; 180 mg) tablets)
Over the Counter
Oral
Tablets
Antihistamines
Indications/Usage:

Used for the temporary relief of the following symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat.


Typical Dosing:  

►Runny nose; sneezing; itchy, watery eyes; itching of the nose or throat:

  • 24-hour tablets (180 mg each):
    • Adults and children 12 years of age:
      • Take one 180 mg tablet with water once a day.
      • Do not take more than 1 tablet in 24 hours.
    • Children < 12 years of age:
      • Do not use.
    • Adults  65 years of age:
      • Ask a doctor.
    • Individuals with kidney disease:
      • Ask a doctor.
  • 12-hour tablets (60 mg each):
    • Adults and children 12 years of age:
      • Take one 60 mg tablet with water every 12 hours.
      • Do not take more than 2 tablets in 24 hours.
    • Children < 12 years of age:
      • Do not use.
    • Adults  65 years of age:
      • Ask a doctor.
    • Individuals with kidney disease:
      • Ask a doctor.

How Supplied:  
  • Tablets:
    • 180 mg 24-hour tablets
    • 180 mg 24-hour tablets, coated (gelcaps)
    • 60 mg 12-hour tablets

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store between 68º  77ºF (20º  25ºC).
  • Protect from excessive moisture.


FEXOFENADINE CHILDREN'S (fexofenadine hydrochloride (30 mg) tablets, orally disintegrating; (30 mg/5 mL) oral suspension)
Over the Counter
Oral
Oral Disintegrating Tablets
Oral Suspension
Antihistamines
Indications/Usage:

Used for the temporary relief of the following symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat.


Typical Dosing:  

►Runny nose; sneezing; itchy, watery eyes; itching of the nose or throat:

  • Tablets, orally disintegrating (30 mg each):
    • Adults and children 12 years of age:
      • Place 1 tablet on tongue; tablet disintegrates, with or without water.
      • Take 2 tablets every 12 hours on an empty stomach.
      • Do not take more than 4 tablets in 24 hours.
    • Children 6 to 12 years of age:
      • Place 1 tablet on tongue; tablet disintegrates, with or without water.
      • Take 1 tablet every 12 hours on an empty stomach.
      • Do not take more than 2 tablets in 24 hours.
    • Children < 6 years of age:
      • Do not use.
    • Adults  65 years of age:
      • Ask a doctor.
    • Individuals with kidney disease:
      • Ask a doctor.
  • Suspension (30 mg/5 mL):
    • Adults and children 12 years of age:
      • Shake well before using.
      • Use only with enclosed dosing cup.
      • Take 10 mL every 12 hours.
      • Do not take more than 20 mL in 24 hours.
    • Children 2 to < 12 years of age:
      • Shake well before using.
      • Use only with enclosed dosing cup.
      • Take 5 mL every 12 hours.
      • Do not take more than 10 mL in 24 hours.
    • Children < 2 years of age:
      • Ask a doctor.
    • Adults 65 years of age:
      • Ask a doctor.
    • Individuals with kidney disease:
      • Ask a doctor.

How Supplied:  
  • Tablets, orally disintegrating:
    • 30 mg orally disintegrating tablets
  • Oral suspension:
    • 30 mg/5 mL oral suspension (118 mL bottles)

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store between 68º  77ºF (20º  25ºC).
  • Protect from excessive moisture.


FLAGYL (metronidazole (375 mg) capsules; (250 mg; 500 mg) tablets)
Prescription
Oral
Capsules
Tablets
Antibiotics, Other Anti-infectives
Indications/Usage:

Indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with FLAGYL therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to FLAGYL 375 capsules. Specifically, indicated for the treatment of skin and skin structure infections caused by Bacteroides species including the B. fragilis group, Clostridioides (formerly Clostridium) species, Peptococcus species, Peptostreptococcus species, or Fusobacterium species.

Consult package insert for additional information.

This medication has a broad FDA approval for "skin and skin structure infections." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "skin and skin structure infections." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Skin and skin structure infections caused by Bacteroides species including the B. fragilis group, Clostridioides (formerly Clostridium) species, Peptococcus species, Peptostreptococcus species, or Fusobacterium species:

  • In the treatment of most serious anaerobic infections, usuallly initially administered intravenously.
  • The usual adult oral dosage is 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult):
    • A maximum of 4 g should not be exceeded during a 24-hour period.
    • The usual duration of therapy is 7– 10 days; however, infections of the bone and joint, lower respiratory tract, and endocardium may require longer treatment.
  • Consult package insert for renal and hepatic dose adjustments and for additional information.

How Supplied:  
  • Capsules:
    • 375 mg capsules
  • Tablets:
    • 250 mg tablets
    • 500 mg tablets

Preservatives:  

None listed in package insert.


Storage:  
  • Store between 59° – 77°F (15° – 25°C).
  • Protect from light.


FLAREX (fluorometholone acetate (0.1%) ophthalmic suspension)
Prescription
Topical
Ophthalmic Suspension
Allergy Corticosteroids, Anti-inflammatory Corticosteroids
Indications/Usage:

Indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye.

This medication has a broad FDA approval for "steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye:  

  • Shake well before using.
  • Instill 1 –  2 drops into the conjunctival sac(s) 4 times daily. During the initial 24 – 48 hours the dosage may be safely increased to 2 drops every 2 hours.
  • If no improvement after 2 weeks, consult physician. Care should be taken not to discontinue therapy prematurely.

How Supplied:  
  • 5 mL bottles

Preservatives:  

benzalkonium chloride


Storage:  
  • Store upright between 36° – 77°F (2° – 25°C).
  • Protect from freezing.


FLUCAINE (fluorescein sodium (0.25%) – proparacaine hydrochloride (0.5%) ophthalmic solution)
Prescription
Topical
Ophthalmic Solution
Anesthetic Medications, Diagnostic Dyes
Indications/Usage:

Used for removal of foreign bodies and sutures, and for tonometry and for deep ophthalmic anesthesia.

This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

Typical Dosing:  

►Foreign bodies, sutures, tonometry, usual dosage: 

  • Instill 1 – 2 drops (in single instillations) in each eye before operating.
  • The use of an eye patch is recommended.

►Deep ophthalmic anesthesia: 

  • Instill 1 drop in each eye every 5 – 10 minutes for 5 – 7 doses.
  • The use of an eye patch is recommended.

How Supplied:  
  • 5 mL bottles

Preservatives:  

methylparaben


Storage:  
  • Store in refrigerator at 36° – 46°F (2° – 8°C).  
  • Can be stored at room temperature for up to 1 month. 


FLUCONAZOLE (fluconazole (10 mg/mL; 40 mg/mL) oral suspension; (50 mg; 100 mg; 150 mg; 200 mg) tablets)
Prescription
Oral
Oral Suspension
Tablets
Antifungals
Indications/Usage:

Used for the treatment of patients with fungal corneal ulcer or fungal keratitis.

Consult package insert for additional information.

This medication is not FDA approved specifically for ophthalmic conditions. Under our interpretation of supporting peer-reviewed studies we have linked this medication with conditions we understand may benefit from off-label use of this medication. This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Fungal corneal ulcer or fungal keratitis:

  • 200 – 400 mg on the first day, followed by 100 – 200 mg once daily.
  • The daily dose of fluconazole for the treatment of infections other than vaginal candidiasis should be based on the infecting organism and the patient's response to therapy.
  • Treatment should be continued until clinical parameters or laboratory tests indicate that active fungal infection has subsided.
  • An inadequate period of treatment may lead to recurrence of active infection.
  • Consult package insert for additional information.
Dosing for ophthalmic indications is based on professional judgment. This is our medical opinion and may not be true in all clinical circumstances.

How Supplied:  
  • Oral suspension:
    • 10 mg/mL oral suspension
    • 40 mg/mL oral suspension
  • Tablets:
    • 50 mg tablets
    • 100 mg tablets
    • 150 mg tablets 
    • 200 mg tablets

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
    Oral suspension:
    • Store dry powder below 86°F (30°C).
    • Store reconstituted suspension between 41° – 86°F (5° – 30°C).
    • Discard unused portion after 2 weeks.
    • Protect from freezing.
  • Tablets:
    • Store below 86°F (30°C).


FLUORESCITE (fluorescein sodium (10%) intravenous solution)
Prescription
Injectable
IV
Diagnostic Dyes
Indications/Usage:

Indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature.


Typical Dosing:  

►Diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature:

  • Adults, recommended: 
    • Inject 500 mg (5 mL) via intravenous administration.
  • Children, recommended: 
    • Calculated on the basis of 7.7 mg/kg (actual body weight or 35 mg for each 10 lbs of body weight) up to a maximum of 500 mg via intravenous administration.
  • Additional information for Dosage and Administration is in Notes below.

How Supplied:  
  • 5 mL single-use vials

Preservatives:  

None listed in package insert.


Storage:  
  • Store at 36° – 77°F (2° – 25°C). 
  • Do not freeze.


FLUOROMETHOLONE (fluorometholone (0.1%) ophthalmic suspension)
Prescription
Topical
Ophthalmic Suspension
Allergy Corticosteroids, Anti-inflammatory Corticosteroids
Indications/Usage:

Indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

This medication has a broad FDA approval for "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe:

  • Shake well before using.
  • Instill 1 drop into the conjunctival sac 2 – 4 times daily. During the initial 24 – 48 hours, the dosing frequency may be increased to 1 application every 4 hours. Care should be taken not to discontinue therapy prematurely.
  • If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (See PRECAUTIONS in package insert).
  • The dosing of fluorometholone suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.

How Supplied:  
  • 5 mL bottles
  • 10 mL bottles

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 36° – 77°F (2° – 25°C).
  • Protect from freezing.
  • Store in an upright position.


FLURBIPROFEN (flurbiprofen sodium (0.03%) ophthalmic solution)
Prescription
Topical
Ophthalmic Solution
NSAIDS
Indications/Usage:

Indicated for the inhibition of intraoperative miosis.


Typical Dosing:  

►Inhibition of intraoperative miosis: 

  • A total of 4 drops should be administered by instilling 1 drop approximately every ½ hour beginning 2 hours before surgery.

How Supplied:  
  • 2.5 mL bottles

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 59° – 77°F (15° – 25°C).


FML (fluorometholone (0.1%) ophthalmic ointment; ophthalmic suspension)
Prescription
Topical
Ointment
Ophthalmic Suspension
Allergy Corticosteroids, Anti-inflammatory Corticosteroids
Indications/Usage:

Indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

This medication has a broad FDA approval for "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe:

  • Ophthalmic ointment:
    • Apply a small amount (approximately ½ inch ribbon) of ointment to the conjunctival sac, 1 – 3 times daily. During the initial 24 – 48 hours, the dosing frequency may be increased to 1 application every 4 hours. Care should be taken not to discontinue therapy prematurely.
    • If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.
    • The dosing may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.
  • Ophthalmic suspension:
    • Shake well before using.
    • Instill 1 drop into the conjunctival sac 2 – 4 times daily. During the initial 24 – 48 hours, the dosing frequency may be increased to 1 application every 4 hours. Care should be taken not to discontinue therapy prematurely.
    • If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (See PRECAUTIONS in package insert).
    • The dosing of FML® suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.

How Supplied:  
  • Ophthalmic ointment:
    • 3.5 g tubes
  • Ophthalmic suspension:
    • 5 mL bottles
    • 10 mL bottles

Preservatives:  

phenylmercuric acetate (ophthalmic ointment); benzalkonium chloride (ophthalmic suspension)


Storage:  

Ophthalmic ointment:

  • Store at 59° – 77°F (15° – 25°C).
  • Avoid exposure to temperatures above 104°F (40°C).

Ophthalmic suspension:

  • Store at 36° – 77°F (2° – 25°C).
  • Protect from freezing.
  • Store in an upright position.


FML FORTE (fluorometholone (0.25%) ophthalmic suspension)
Prescription
Topical
Ophthalmic Suspension
Allergy Corticosteroids, Anti-inflammatory Corticosteroids
Indications/Usage:

Indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

This medication has a broad FDA approval for "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

►Corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe:

  • Shake well bebore using.
  • Instill 1 drop into the conjunctival sac, 2 – 4 times daily. During the initial 24 – 48 hours, the dosing frequency may be increased to 1 application every 4 hours. Care should be taken not to discontinue therapy prematurely.
  • If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.
  • The dosing may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.

How Supplied:  
  • 5 mL bottles
  • 10 mL bottles

Preservatives:  

benzalkonium chloride


Storage:  
  • Store at 36° – 77°F (2° – 25°C). 
  • Protect from freezing.
  • Store in an upright position.


GATIFLOXACIN (gatifloxacin (0.5%) ophthalmic solution)
Prescription
Topical
Ophthalmic Solution
Antibiotics
Indications/Usage:

Indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus mitis group*; Streptococcus oralis*; Streptococcus pneumoniae. Aerobic gram-negative bacteria: Haemophilus influenzae.

*Efficacy for this organism was studied in fewer than 10 infections.


Typical Dosing:  

►Bacterial conjunctivitis caused by susceptible strains of listed organisms:

  •  Patients  1 year of age: 
    • Instill 1 drop every 2 hours in the affected eye(s) while awake, up to 8 times on day 1.
    • Instill 1 drop 2 – 4 times daily in the affected eye(s) while awake on days 2 – 7.

How Supplied:  
  • 2.5 mL bottles

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 59° – 77°F (15° – 25°C).
  • Protect from freezing.


GENTAK (gentamicin sulfate (0.3%) ophthalmic ointment)
Prescription
Topical
Ointment
Ophthalmic Solution
Antibiotics
Indications/Usage:

Indicated for the topical treatment of ocular bacterial infections, including: conjunctivitis; keratitis; keratoconjunctivitis; corneal ulcers; blepharitis; blepharoconjunctivitis; acute meibomianitis; dacrocystitis caused by susceptible strains of the following microoranisms: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pyogenes; Streptococcus pneumoniae; Enterobacter aerogenes; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Neisseria gonorrhoeae; Pseudomonas aeruginosa; and Serratia marcescens.


Typical Dosing:  

►Ocular bacterial infections:

  • Apply a small amount (approximately ½ inch ribbon) of ointment to the affected eye(s) 2 – 3 times a day.

How Supplied:  
  • 3.5 g tubes

Preservatives:  

methylparaben, propylparaben


Storage:  
  • Store at 36° – 86°F (2° – 30°C).


GENTAMICIN (gentamicin sulfate (0.3%) ophthalmic ointment; (0.3%) ophthalmic solution)
Prescription
Topical
Ointment
Ophthalmic Solution
Antibiotics
Indications/Usage:

Indicated for the topical treatment of ocular bacterial infections, including: conjunctivitis; keratitis; keratoconjunctivitis; corneal ulcers; blepharitis; blepharoconjunctivitis; acute meibomianitis; dacrocystitis caused by susceptible strains of the following microoranisms: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pyogenes; Streptococcus pneumoniae; Enterobacter aerogenes; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Neisseria gonorrhoeae; Pseudomonas aeruginosa; and Serratia marcescens.


Typical Dosing:  

►Ocular bacterial infections:

  • Ophthalmic ointment:
    • Apply a small amount (approximately ½ inch ribbon) of ointment to the affected eye(s) 2 – 3 times a day.
  • Ophthalmic solution:
    • Instill 1 – 2 drops into the affected eye(s) every 4 hours.
    • In severe infections, dosage may be increased to as much as 2 drops every hour.

How Supplied:  
  • Ophthalmic ointment:
    • 3.5 g tubes
  • Ophthalmic solution:
    • 5 mL bottles

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Ophthalmic ointment:
    • Store at 36° – 86°F (2° – 30°C).
  • Ophthalmic solution:
    • Store at 68° – 77°F (20° – 25°C).
    • Avoid exposure to excessive heat.


HETLIOZ (tasimelteon (20 mg) capsules)
Prescription
Oral
Capsules
Other Medications
Indications/Usage:

Indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).


Typical Dosing:  

►Non-24-Hour Sleep-Wake Disorder (Non-24), recommended:

  • 20 mg per day taken before bedtime, at the same time every night.
  • Because of individual differences in circadian rhythms, drug effect may not occur for weeks or months.
  • HETLIOZ should be taken without food [See Clinical Pharmacology (12.3) in package insert].

How Supplied:  
  • 20 mg capsules

Preservatives:  

None listed in package insert.


Storage:  
  • Store at controlled room temperature, 77°F (25°C).
  • Excursions permitted to 59° – 86°F (15° – 30°C).
  • Protect from exposure to light and moisture.


Assistance: Payment Assistance

HOMATROPINE (homatropine hydrobromide (5%) ophthalmic solution)
Prescription
Topical
Ophthalmic Solution
Cycloplegics
Indications/Usage:

A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre- and post-operative states when mydriasis is required. Use as an optical aid in some cases of axial lens opacities.

This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

Typical Dosing:  

►Refraction:

  • Instill 1 – 2 drops topically in the eye(s). May be repeated in 5 – 10 minutes if necessary.

►Uveitis:

  •  Instill 1 – 2 drops topically up to every 3 – 4 hours.
  • Individuals with heavily pigmented irides may require larger doses.

How Supplied:  
  • 5mL bottles

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 59° – 86°F (15° – 30°C).


HYDROCORTISONE (hydrocortisone (1%) topical cream)
Over the Counter
Topical
Cream
Allergy Corticosteroids, Anti-inflammatory Corticosteroids
Indications/Usage:

Indicated for the temporary relief of itching associated with minor skin irritation and rashes due to eczema, insect bites, poison oak, poison sumac, soaps, detergents, cosmetics, jewelry, seborrheic dermatitis, or psoriasis scrapes.

This medication has a broad FDA approval for "minor skin irritation and rashes." Under our interpretation of this indication we have linked this medication with conditions we understand to be categorized as "minor skin irritation and rashes." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

Eyelid dermatitis (allergic, eczematous, or xeroderma):

  • Adults and childre≥ 2 years of age:
    • Apply externally to affected area not more than 3 – 4 times daily.
  • Children < 2 years of age:
    • Do not use, consult a doctor.

How Supplied:  
  • 1% topical cream:
    • 1 g tubes
    • 1.5 g tubes
    • 14.2 g tubes
    • 20 g tubes
    • 28 g tubes
    • 30 g tubes
    • 454 g tubes

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at 59° – 86°F (15° – 30°C).
  • Avoid excessive heat and humidity.


IBUPROFEN (ibuprofen (200 mg; 400 mg; 600 mg; 800 mg) tablets; (200 mg) capsules; (100 mg) chewable tablets; (100 mg/5 mL) oral suspension)
Over the Counter
Oral
Capsules
Chewable Tablets
Oral Suspension
Tablets
NSAIDS
Indications/Usage:

Indicated for relief of mild to moderate pain.


Typical Dosing:  

►Mild to moderate pain:

  • 400 mg every 4 – 6 hours as necessary for relief of pain. In controlled analgesic clinical trials, doses of Ibuprofen tablets greater than 400 mg were no more effective than the 400 mg dose.
  • Carefully consider the potential benefits and risks of Ibuprofen tablets and other treatment options before deciding to use Ibuprofen tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [See Warnings in package insert].
  • After observing the response to initial therapy, the dose and frequency should be adjusted to suit an individual patients' needs.
  • Do not exceed 3200 mg total daily dose.
  • If gastrointestinal complaints occur, administer with meals or milk.

How Supplied:  
  • Capsules:
    • 200 mg capsules
  • Tablets:
    • 200 mg tablets
    • 400 mg tablets
    • 600 mg tablets
    • 800 mg tablets
  • Chewable tablets:
    • 100 mg chewable tablets
  • Oral suspension:
    • 100 mg/5 mL (5 mL; 118 mL; 120 mL; 473 mL bottles)

Preservatives:  

Preservatives may vary across product manufacturers. Consult individual package inserts.


Storage:  
  • Store at room temperature.
  • Avoid excessive heat – 104°F (40°C).


ILEVRO (nepafenac (0.3%) ophthalmic suspension)
Prescription
Topical
Ophthalmic Suspension
NSAIDS
Indications/Usage:

Indicated for the treatment of pain and inflammation associated with cataract surgery.


Typical Dosing:  

►Pain and inflammation associated with cataract surgery, recommended:

  • 1 drop should be applied to the affected eye 1 time daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the post-operative period. An additional drop should be administered 30 to 120 minutes prior to surgery.
  • Use with other topical ophthalmic medications:
    • May be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
    • If more than 1 topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.

How Supplied:  
  • 1.7 mL bottles
  • 3 mL bottles

Preservatives:  

benzalkonium chloride


Storage:  
  • Store at 36˚ – 77˚F (2˚ – 25˚C).
  • Protect from light.


Assistance: Payment Assistance

224 items found